LABORATORY REPORT

If you have any questions concerning this report, please do not hesitate to call us at (800) 332-4345 or (574) 233-4777.

This report may not be reproduced, except in full, without written approval from EEA.

Page 1 of 14

 

       

STATE CERTIFICATION LIST

State Certification State Certification Alabama 40700 Missouri 880 Alaska IN00035 Montana CERT0026 Arizona AZ0432 Nebraska NE-OS-05-04

Arkansas IN00035 Nevada IN00035 California 2920 New Hampshire* 2124 Colorado IN00035 New Jersey* IN598

Colorado Radiochemistry IN00035 New Mexico IN00035 Connecticut PH-0132 New York* 11398 Delaware IN035 North Carolina 18700 Florida* E87775 North Dakota R-035 Georgia 929 Ohio 87775 Hawaii IN035 Oklahoma D9508 Idaho IN00035 Oregon (Primary AB)* 4074

Illinois* 200001 Pennsylvania* 68-00466 Illinois Microbiology 17767 Puerto Rico IN00035

Illinois Radiochemistry IN00035 Rhode Island LAO00343 Indiana Chemistry C-71-01 South Carolina 95005

Indiana Microbiology M-76-07 South Dakota IN00035 Iowa 098 Tennessee TN02973

Kansas* E-10233 Texas* T104704187-18-12 Kentucky 90056 Texas/TCEQ TX207

Louisiana* LA014 Utah* IN00035 Maine IN00035 Vermont VT-8775

Maryland 209 Virginia* 460275 Massachusetts M-IN035 Washington C837

Michigan 9926 West Virginia 9927 C Minnesota* 018-999-338 Wisconsin 999766900 Mississippi IN035 Wyoming IN035

EPA IN00035 *NELAP/TNI Recognized Accreditation Bodies

Revision date: 03/14/2019

Page 2 of 14

110 South Hill Street South Bend, IN 46617 Tel: (574) 233-4777 Fax: (574) 233-8207 1 800 332 4345

Laboratory Report

Client: Hillsborough County Board of County Commissioners Report: 498115

Attn: Ed Watson

332 N. Falkenburd Rd.

Tampa, FL 33619

Priority:

Status:

Standard Written

Final

Lab ID Code: IN00035

PWS Facility ID:

Sampling Point ID:

Sample Event Code:

00001

0333001

SE6

PWS ID: FL6290333

EEA ID #

Client ID Method Collected Date / Time

Collected By:

4724988 SB-017 545

Received Date / Time

09/14/20 08:52 Client 09/15/20 09:45

4724989 SB-017 546 09/14/20 08:52 Client 09/15/20 09:45

Sample Information

Report Summary

Detailed quantitative results are presented on the following pages. The results presented relate only to the samples provided for analysis.

We appreciate the opportunity to provide you with this analysis. If you have any questions concerning this report, please do not hesitate to call Jessie Brasch at (574) 233-4777.

Note: This report may not be reproduced, except in full, without written approval from EEA.

09/25/2020

Authorized Signature Title Date

Client Name: Hillsborough County Board of County Commissioners

Report #: 498115 Page 1 of 2

Page 3 of 14

Client Name: Hillsborough County Board of County Commissioners Report #: 498115

Sampling Point ID: 0333001 PWS ID: FL6290333

UCMR Result Summary

Analyte ID #

Analyte Method MRL† Result Units Preparation Date

Analyzed Date

EEA ID #

3311 Anatoxin-a 545 0.0300 < 0.0300 ug/L 09/17/20 13:25 09/17/20 21:34 4724988

3302 Cylindrospermopsin 545 0.0900 < 0.0900 ug/L 09/17/20 13:25 09/17/20 21:34 4724988

3301 Total Microcystins & Nodularins 546 0.300 < 0.300 ug/L 09/22/20 16:35 09/23/20 15:33 4724989

CVTM Percent CV 546 N/A 1.60 % 09/22/20 16:35 09/23/20 15:33 4724989

† EEA has demonstrated it can achieve these report limits in reagent water, but can not document them in all sample matrices.

Page 2 of 2

Page 4 of 14

Lab Definitions

Continuing Calibration Check Standard (CCC) / Continuing Calibration Verification (CCV) / Initial Calibration Verification Standard (ICV) / Initial Performance Check (IPC) - is a standard containing one or more of the target analytes that is prepared from the same standards used to calibrate the instrument. This standard is used to verify the calibration curve at the beginning of each analytical sequence, and may also be analyzed throughout and at the end of the sequence. The concentration of continuing standards may be varied, when prescribed by the reference method, so that the range of the calibration curve is verified on a regular basis. CCL, CCM, and CCH are the CCC standards at low, mid, and high concentration levels, respectively.

Internal Standards (IS) - are pure compounds with properties similar to the analytes of interest, which are added to field samples or extracts, calibration standards, and quality control standards at a known concentration. They are used to measure the relative responses of the analytes of interest and surrogates in the sample, calibration standard or quality control standard.

Laboratory Duplicate (LD) - is a field sample aliquot taken from the same sample container in the laboratory and analyzed separately using identical procedures. Analysis of laboratory duplicates provides a measure of the precision of the laboratory procedures.

Laboratory Fortified Blank (LFB) / Laboratory Control Sample (LCS) - is an aliquot of reagent water to which known concentrations of the analytes of interest are added. The LFB is analyzed exactly the same as the field samples. LFBs are used to determine whether the method is in control. FBL, FBM, and FBH are the LFB samples at low, mid, and high concentration levels, respectively.

Laboratory Method Blank (LMB) / Laboratory Reagent Blank (LRB) - is a sample of reagent water included in the sample batch analyzed in the same way as the associated field samples. The LMB is used to determine if method analytes or other background contamination have been introduced during the preparation or analytical procedure. The LMB is analyzed exactly the same as the field samples.

Laboratory Trip Blank (LTB) / Field Reagent Blank (FRB) - is a sample of laboratory reagent water placed in a sample container in the laboratory and treated as a field sample, including storage, preservation, and all analytical procedures. The FRB/LTB container follows the collection bottles to and from the collection site, but the FRB/LTB is not opened at any time during the trip. The FRB/LTB is primarily a travel blank used to verify that the samples were not contaminated during shipment.

If applicable, the calculation of the matrix spike (MS) or matrix spike duplicate (MSD) percent recovery is as follows: (MS or MSD value - Sample value) * 100 / spike target / dilution factor = Recovery %

Matrix Spike Duplicate Sample (MSD) / Laboratory Fortified Sample Matrix Duplicate (LFSMD) - is a sample aliquot taken from the same field sample source as the Matrix Spike Sample to which known quantities of the analytes of interest are added in the laboratory. The MSD is analyzed exactly the same as the field samples. Analysis of the MSD provides a measure of the precision of the laboratory procedures in a specific matrix. SDL, SDM, and SDH / LFSMDL, LFSMDM, and LFSMDH are the MSD or LFSMD at low, mid, and high concentration levels, respectively.

Matrix Spike Sample (MS) / Laboratory Fortified Sample Matrix (LFSM) - is a sample aliquot taken from field sample source to which known quantities of the analytes of interest are added in the laboratory. The MS is analyzed exactly the same as the field samples. The purpose is to demonstrate recovery of the analytes from a sample matrix to determine if the specific matrix contributes bias to the analytical results. MSL, MSM, and MSH / LFSML, LFSMM, and LFSMH are the MS or LFSM at low, mid, and high concentration levels, respectively.

Quality Control Standard (QCS) / Second Source Calibration Verification (SSCV) - is a solution containing known concentrations of the analytes of interest prepared from a source different from the source of the calibration standards. The solution is obtained from a second manufacturer or lot if the lot can be demonstrated by the manufacturer as prepared independently from other lots. The QCS sample is analyzed using the same procedures as field samples. The QCS is used as a check on the calibration standards used in the method on a routine basis.

Reporting Limit Check (RLC) / Initial Calibration Check Standard (ICCS) - is a procedural standard that is analyzed each day to evaluate instrument performance at or below the minimum reporting limit (MRL).

Surrogate Standard (SS) / Surrogate Analyte (SUR) - is a pure compound with properties similar to the analytes of interest, which is highly unlikely to be found in any field sample, that is added to the field samples, calibration standards, blanks and quality control standards before sample preparation. The SS is used to evaluate the efficiency of the sample preparation process.

Page 1 of 1

Page 5 of 14

110 South Hill Street South Bend, IN 46617 Tel: (574) 233-4777 Fax: (574) 233-8207 1 800 332 4345

Laboratory Report

Client: Hillsborough County Board of County Commissioners Report: 498115

Attn: Ed Watson Priority: Standard Written

332 N. Falkenburd Rd. Status: Final

Tampa, FL 33619 PWS ID: FL6290333

EEA ID #

Client ID Method Collected Date / Time

Collected By:

Received Date / Time

Sample Information

Report Summary

4724987 SB-017 544 09/14/20 08:52 Client 09/15/20 09:45

Method 544 analysis will be performed only if the associated Screening Microcystin by EPA 546 sample result is >=0.3 ug/L.

We appreciate the opportunity to provide you with this analysis. If you have any questions concerning this report, please do not hesitate to call Jessie Brasch at (574) 233-4777.

Note: This report may not be reproduced, except in full, without written approval from EEA.

09/25/2020

Authorized Signature Title Date

Page 1 of 1

Page 6 of 14

Page 7 of 14

Page 8 of 14

0.0

0

Eu

rofi

ns

Ea

ton

An

aly

tica

l R

un

Lo

g R

un ID

: 279836

Meth

od:

545

Typ

e

Sam

ple

Id

S

am

ple

Sit

e

Matr

ix

Instr

um

en

t ID

A

naly

sis

Date

C

ali

bra

tio

n F

ile

CC

L

47

27

05

7

RW

C

Y

09

/17

/20

20

17

:39

0

91

72

0M

54

5a

-CY

.md

b

QC

S

47

27

05

8

RW

C

Y

09

/17

/20

20

17

:54

0

91

72

0M

54

5a

-CY

.md

b

LR

B

47

27

05

9

RW

C

Y

09

/17

/20

20

18

:08

0

91

72

0M

54

5a

-CY

.md

b

CC

M

47

27

06

0

RW

C

Y

09

/17

/20

20

20

:50

0

91

72

0M

54

5a

-CY

.md

b

FS

4

72

49

88

SB

-01

7

DW

C

Y

09

/17

/20

20

21

:34

0

91

72

0M

54

5a

-CY

.md

b

CC

H

47

27

06

1

RW

C

Y

09

/18

/20

20

00

:00

0

91

72

0M

54

5a

-CY

.md

b

Page 9 of 14

Page

1 o

f 2

E

EA

Run I

D 2

79836 /

EE

A R

eport

# 4

98115

Fals

e

Fals

e

Fals

e

Fals

e

Tru

e

Tru

e

Tru

e

Tru

e

Fals

e

Fals

e

Fals

e

Fals

e

Tru

e

Tru

e

Tru

e

Tru

e

Fals

e

Fals

e

Fals

e

Fals

e

Tru

e

Tru

e

Tru

e

Tru

e

QC

Su

mm

ary

Re

po

rt

EE

AID

#

RP

DU

nit

sT

arg

et

Am

ou

nt

Clie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

e

Dil

Fa

cto

r R

PD

Lim

it

Re

co

ve

ryL

imit

s

%R

ec

ove

ry

Re

su

ltF

lag

M

RL

E

xtr

ac

ted

A

na

lyze

d

CC

L

IS-L

-phenyl

ala

nin

e-d

5

545

N/A

---

20

96

2

21

54

6

ug

/L

97

50

- 1

50

---

---

1.0

0

9/1

0/2

02

0 1

0:5

5

09

/17

/20

20

17

:39

47

27

05

7

CC

L

IS-U

raci

l-d4

545

N/A

---

11

21

6

11

18

7

ug

/L

10

05

0 -

15

0--

---

-1

.0

09

/10

/20

20

10

:55

0

9/1

7/2

02

0 1

7:3

94

72

70

57

CC

L

Anato

xin-a

545

0.0

300

---

0.0

24

60

3

0.0

3

ug

/L

82

50

- 1

50

---

---

1.0

0

9/1

0/2

02

0 1

0:5

5

09

/17

/20

20

17

:39

47

27

05

7

CC

L

Cyl

indro

sperm

opsi

n

545

0.0

900

---

0.0

77

70

2

0.0

9

ug

/L

86

50

- 1

50

---

---

1.0

0

9/1

0/2

02

0 1

0:5

5

09

/17

/20

20

17

:39

47

27

05

7

QC

S

IS-L

-phenyl

ala

nin

e-d

5

545

N/A

---

21

46

9

21

54

6

ug

/L

10

05

0 -

15

0--

---

-1

.0

09

/10

/20

20

10

:55

0

9/1

7/2

02

0 1

7:5

44

72

70

58

QC

S

IS-U

raci

l-d4

545

N/A

---

11

37

8

11

18

7

ug

/L

10

25

0 -

15

0--

---

-1

.0

09

/10

/20

20

10

:55

0

9/1

7/2

02

0 1

7:5

44

72

70

58

QC

S

Anato

xin-a

545

0.0

300

---

0.5

78

84

6

0.5

ug

/L

11

67

0 -

13

0--

---

-1

.0

09

/10

/20

20

10

:55

0

9/1

7/2

02

0 1

7:5

44

72

70

58

QC

S

Cyl

indro

sperm

opsi

n

545

0.0

900

---

1.4

04

91

1

.5

ug

/L

94

70

- 1

30

---

---

1.0

0

9/1

0/2

02

0 1

0:5

5

09

/17

/20

20

17

:54

47

27

05

8

LR

B

IS-L

-phenyl

ala

nin

e-d

5

545

N/A

---

22

36

4

21

54

6

ug

/L

10

45

0 -

15

0--

---

-1

.0

09

/17

/20

20

13

:25

0

9/1

7/2

02

0 1

8:0

84

72

70

59

LR

B

IS-U

raci

l-d4

545

N/A

---

11

71

6

11

18

7

ug

/L

10

55

0 -

15

0--

---

-1

.0

09

/17

/20

20

13

:25

0

9/1

7/2

02

0 1

8:0

84

72

70

59

LR

B

Anato

xin-a

545

0.0

300

---

<

0.0

ug

/L

---

---

---

---

1.0

0

9/1

7/2

02

0 1

3:2

5

09

/17

/20

20

18

:08

47

27

05

9

LR

B

Cyl

indro

sperm

opsi

n

545

0.0

900

---

<

0.0

ug

/L

---

---

---

---

1.0

0

9/1

7/2

02

0 1

3:2

5

09

/17

/20

20

18

:08

47

27

05

9

CC

M

IS-L

-phenyl

ala

nin

e-d

5

545

N/A

---

18

03

5

21

54

6

ug

/L

84

50

- 1

50

---

---

1.0

0

9/1

0/2

02

0 1

0:5

5

09

/17

/20

20

20

:50

47

27

06

0

CC

M

IS-U

raci

l-d4

545

N/A

---

99

93

1

11

87

ug

/L

89

50

- 1

50

---

---

1.0

0

9/1

0/2

02

0 1

0:5

5

09

/17

/20

20

20

:50

47

27

06

0

CC

M

Anato

xin-a

545

0.0

300

---

0.5

24

69

4

0.5

ug

/L

10

57

0 -

13

0--

---

-1

.0

09

/10

/20

20

10

:55

0

9/1

7/2

02

0 2

0:5

04

72

70

60

CC

M

Cyl

indro

sperm

opsi

n

545

0.0

900

---

1.5

54

17

1

.5

ug

/L

10

47

0 -

13

0--

---

-1

.0

09

/10

/20

20

10

:55

0

9/1

7/2

02

0 2

0:5

04

72

70

60

FS

IS

-L-p

henyl

ala

nin

e-d

5

545

N/A

SB

-01

7

18

95

2

21

54

6

ug

/L

88

50

- 1

50

---

---

1.0

0

9/1

7/2

02

0 1

3:2

5

09

/17

/20

20

21

:34

47

24

98

8

FS

IS

-Ura

cil-

d4

545

N/A

SB

-01

7

10

39

2

11

18

7

ug

/L

93

50

- 1

50

---

---

1.0

0

9/1

7/2

02

0 1

3:2

5

09

/17

/20

20

21

:34

47

24

98

8

FS

A

nato

xin-a

545

0.0

300

SB

-01

7

<

0.0

30

0

ug

/L

---

---

---

---

1.0

0

9/1

7/2

02

0 1

3:2

5

09

/17

/20

20

21

:34

47

24

98

8

FS

C

ylin

dro

sperm

opsi

n

545

0.0

900

SB

-01

7

<

0.0

90

0

ug

/L

---

---

---

---

1.0

0

9/1

7/2

02

0 1

3:2

5

09

/17

/20

20

21

:34

47

24

98

8

CC

H

IS-L

-phenyl

ala

nin

e-d

5

545

N/A

---

17

35

6

21

54

6

ug

/L

81

50

- 1

50

---

---

1.0

0

9/1

0/2

02

0 1

0:5

5

09

/18

/20

20

00

:00

47

27

06

1

CC

H

IS-U

raci

l-d4

545

N/A

---

96

68

1

11

87

ug

/L

86

50

- 1

50

---

---

1.0

0

9/1

0/2

02

0 1

0:5

5

09

/18

/20

20

00

:00

47

27

06

1

CC

H

Anato

xin-a

545

0.0

300

---

1.9

82

12

2

.0

ug

/L

99

70

- 1

30

---

---

1.0

0

9/1

0/2

02

0 1

0:5

5

09

/18

/20

20

00

:00

47

27

06

1

CC

H

Cyl

indro

sperm

opsi

n

545

0.0

900

---

5.7

37

93

6

.0

ug

/L

96

70

- 1

30

---

---

1.0

0

9/1

0/2

02

0 1

0:5

5

09

/18

/20

20

00

:00

4

72

70

61

Page 10 of 14

Page

2 o

f 2

E

EA

Run I

D 2

79836 /

EE

A R

eport

# 4

98115

0.0

0

Typ

e

Sam

ple

Id

LR

B

47

30

98

6

LF

B

47

30

98

8

CC

L

47

30

99

0

LR

B

47

30

98

6

FS

4

72

49

89

LR

B

47

30

98

7

LF

B

47

30

98

9

QC

S

47

30

99

1

FS

4

72

49

89

LR

B

47

30

98

7

Sam

ple

Sit

e

SB

-01

7

SB

-01

7

Eu

rofi

ns

Ea

ton

An

aly

tica

l R

un

Lo

g R

un ID

: 280041

Meth

od:

546

Matr

ix

Instr

um

en

t ID

RW

F

H

RW

F

H

RW

F

H

RW

F

H

DW

F

H

RW

F

H

RW

F

H

RW

F

H

DW

F

H

RW

F

H

An

aly

sis

Date

C

ali

bra

tio

n F

ile

09

/23

/20

20

14

:01

09

/23

/20

20

14

:01

09

/23

/20

20

14

:01

09

/23

/20

20

14

:01

09

/23

/20

20

15

:33

09

/23

/20

20

15

:33

09

/23

/20

20

15

:33

09

/23

/20

20

15

:33

09

/23

/20

20

15

:33

09

/23

/20

20

15

:33

Page 11 of 14

Page

1 o

f 2

E

EA

Run I

D 2

80041 /

EE

A R

eport

# 4

98115

Tru

e

Tru

e

Fals

e

Tru

e

Fals

e

Fals

e

Tru

e

Tru

e

Fals

e

Tru

e

QC

Su

mm

ary

Re

po

rt

EE

AID

#

RP

DU

nit

sT

arg

et

Am

ou

nt

Clie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

e

Dil

Fa

cto

r R

PD

Lim

it

Re

co

ve

ryL

imit

s

%R

ec

ove

ry

Re

su

ltF

lag

M

RL

E

xtr

ac

ted

A

na

lyze

d

LR

B

Tota

l M

icro

cyst

ins

& N

odula

rins

546

0.3

00

---

<

0.0

42

ug

/L

---

---

---

---

1.0

0

9/2

2/2

02

0 1

6:3

5

09

/23

/20

20

14

:01

47

30

98

6

LR

B

Perc

ent C

V

546

N/A

---

<

0.4

%

--

---

---

---

-1

.0

09

/22

/20

20

16

:35

0

9/2

3/2

02

0 1

4:0

14

73

09

86

LF

B

Tota

l M

icro

cyst

ins

& N

odula

rins

546

0.3

00

---

0.4

71

99

9

0.5

ug

/L

94

60

- 1

40

---

---

1.0

0

9/2

2/2

02

0 1

6:3

5

09

/23

/20

20

14

:01

47

30

98

8

CC

L

Tota

l M

icro

cyst

ins

& N

odula

rins

546

0.3

00

---

0.3

65

99

9

0.3

ug

/L

12

25

0 -

15

0--

---

-1

.0

---

09

/23

/20

20

14

:01

47

30

99

0

FS

T

ota

l M

icro

cyst

ins

& N

odula

rins

546

0.3

00

SB

-01

7

<

0.3

00

ug

/L

---

---

---

---

1.0

0

9/2

2/2

02

0 1

6:3

5

09

/23

/20

20

15

:33

47

24

98

9

FS

P

erc

ent C

V

546

N/A

SB

-01

7

2

%

---

---

---

---

1.0

0

9/2

2/2

02

0 1

6:3

5

09

/23

/20

20

15

:33

47

24

98

9

LR

B

Tota

l M

icro

cyst

ins

& N

odula

rins

546

0.3

00

---

<

0.0

03

ug

/L

---

---

---

---

1.0

0

9/2

2/2

02

0 1

6:3

5

09

/23

/20

20

15

:33

47

30

98

7

LR

B

Perc

ent C

V

546

N/A

---

2.5

%

--

---

---

---

-1

.0

09

/22

/20

20

16

:35

0

9/2

3/2

02

0 1

5:3

34

73

09

87

LF

B

Tota

l M

icro

cyst

ins

& N

odula

rins

546

0.3

00

---

0.4

80

99

9

0.5

ug

/L

96

60

- 1

40

---

---

1.0

0

9/2

2/2

02

0 1

6:3

5

09

/23

/20

20

15

:33

47

30

98

9

QC

S

Tota

l M

icro

cyst

ins

& N

odula

rins

546

0.3

00

---

0.6

32

0

.6

ug

/L

10

57

0 -

13

0--

---

-1

.0

---

09

/23

/20

20

15

:33

4

73

09

91

Page 12 of 14

Page

2 o

f 2

E

EA

Run I

D 2

80041 /

EE

A R

eport

# 4

98115

1.0

0

CC

L

Sa

mp

le T

yp

e K

ey

Typ

e (

Ab

br.

) S

am

ple

Typ

e

Typ

e (

Ab

br.

) S

am

ple

Typ

e

CC

H

Contin

uin

g C

alib

ratio

n H

igh

Contin

uin

g C

alib

ratio

n L

ow

CC

M

Contin

uin

g C

alib

ratio

n M

id

FS

F

ield

Sam

ple

LF

B

Labora

tory

Fort

ifie

d B

lank

LR

B

Labora

tory

Reagent

Bla

nk

QC

S

Qualit

y C

ontr

ol S

am

ple

Page 13 of 14

END OF REPORT

Page 14 of 14